News

Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder

VANCOUVER, British Columbia, May 22, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading…

2 years ago

Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises

May 22, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises Proceeds…

2 years ago

AGC Biologics and BioConnection Partner to Offer new End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering

         AGC Biologics and BioConnection Partner to Offer new End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering…

2 years ago

MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development

Legend Biotech obtains license to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support its non-viral engineered pipeline portfolio…

2 years ago

Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference

WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to…

2 years ago

Therma Bright Announces up to $1,000,000 Unit Offering

Toronto, Ontario--(Newsfile Corp. - May 22, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer…

2 years ago

HYAS Infosec Named “Best Overall Healthcare Cybersecurity Company” in 8th Annual MedTech Breakthrough Awards Program

HYAS Insight Advanced Threat Intelligence and HYAS Protect Protective DNS Proactively Thwart Attacks on the Healthcare Sector Before Damage Can…

2 years ago

OrganOx Opens State-of-the-Art Research, Development, and Production Headquarters in Oxford, UK

OXFORD, England & MADISON, N.J.--(BUSINESS WIRE)--OrganOx Ltd, a world-leading medical technology company developing innovative solutions for organ preservation prior to…

2 years ago

Evotec Reports Q1 2024 Results and Provides Corporate Update

CHALLENGING Q1 WITH SOFTNESS MAINLY IN TRANSACTIONAL/DEVELOPMENT SHARED R&D BUSINESS AGAINST A STRONG COMPARABLE QUARTERSTRONG START WITH JUST - EVOTEC…

2 years ago

IRLAB Broadcasts the Annual General Meeting Live

GOTHENBURG, SWEDEN / ACCESSWIRE / May 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 22, 2024 - IRLAB Therapeutics…

2 years ago